Fri, Jul 11, 2014, 4:36 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Dais Analytic Corporation Message Board

disconnected6060842 17 posts  |  Last Activity: Jun 24, 2014 1:00 PM Member since: Mar 26, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • disconnected6060842 disconnected6060842 Jun 24, 2014 1:00 PM Flag

    GTHP does have sound technology, but when some idiot (you and your aliases, jennifer_jkarim, etc.) comes along a spams message boards ad nauseam it gives it the appearance of a pump and dump. Crawl back in your hole...and have a nice day.

  • disconnected6060842 disconnected6060842 Jun 23, 2014 9:45 AM Flag

    82 posts since June 18. Ignore.

    82 posts | Last Activity: 31 minutes ago Member since: Jun 18, 2014

  • disconnected6060842 by disconnected6060842 Jun 20, 2014 3:33 PM Flag

    SOURCE: Form 4
    TITLE: Chief Executive Officer
    6/18/14-6/20/14 Purchase 76,000 $0.48 $36,845
    OWNERSHIP: 2,100,000 (Direct)
    The Form 4 is filed with the Securities and Exchange Commission by insiders
    to report transactions in their companies' shares. Open market purchases
    and sales must be reported within two business days of the transaction.

  • disconnected6060842 by disconnected6060842 Jun 18, 2014 6:34 PM Flag

    Not a huge buy but good to see nonetheless.

    SOURCE: Form 4
    TITLE: Chief Executive Officer
    6/17/14 Purchase 24,000 $0.49 $11,714
    OWNERSHIP: 2,024,000 (Direct)
    The Form 4 is filed with the Securities and Exchange Commission by insiders
    to report transactions in their companies' shares. Open market purchases
    and sales must be reported within two business days of the transaction.

  • disconnected6060842 disconnected6060842 Jun 9, 2014 4:13 PM Flag

    "What a maintenance chore."

    Is this sarcasm or are you being serious? It sounds like a ten minute task...twice a year.

  • Reply to

    From Today's ASCO PR

    by disconnected6060842 Jun 2, 2014 8:22 AM
    disconnected6060842 disconnected6060842 Jun 2, 2014 8:25 AM Flag

    "The consistency of these findings across three different cancer indications and the benefit achieved with MM-121 in these studies is evidence of the importance of ErbB3 signaling in cancer. It also strengthens our confidence in systems biology and its applicability to drug discovery and development. With these findings, we are now preparing our diagnostic assays for use in future clinical studies for MM-121 as well as for use in the clinical development of our other ErbB3-targeted therapies," said Gavin MacBeath, Ph.D., Co-Founder and Senior Vice President at Merrimack. "These data lay the foundation for the development of ErbB3 inhibitors in oncology."

  • disconnected6060842 by disconnected6060842 Jun 2, 2014 8:22 AM Flag

    "These data suggest a significant clinical role for heregulin-driven ErbB3 signaling as a mechanism of resistance to multiple standard of care therapies regardless of the cancer indication studied. Moreover, these studies demonstrate that targeting heregulin-positive tumors with MM-121 appeared to sensitize patients to exemestane, erlotinib and paclitaxel in metastatic breast, lung and ovarian cancers, respectively, and significantly lower their risk of tumor progression," said Akos Czibere, MD, PhD, Senior Medical Director at Merrimack. "We look forward to advancing MM-121 into definitive studies that will allow us to prospectively screen patients for heregulin."

  • Reply to

    Investec cuts Smiths Group from buy to hold

    by b9molecule May 27, 2014 2:22 PM
    disconnected6060842 disconnected6060842 May 27, 2014 3:52 PM Flag

    Did you notice Smith's stating its ETD sales were difficult to forecast? They even used the same word Bolduc has used to describe IMSC Q to Q ETD sales - "Lumpy."

  • disconnected6060842 by disconnected6060842 May 22, 2014 5:55 PM Flag

    To get an idea what kind of people IMSC is involved with at Platinum, read the letter that ECTE sent to its shareholders today. Here is an entertaining excerpt. To read the entire letter, Google "Echo Therapeutics Press Releases" and you'll find it there.

    Can that really be the case given the events of June 10, 2013? On that date, as outlined in the Platinum Group's proxy, members of the Platinum Group sold a total of 121,041 shares, or 30% of the shares traded that day. Those members of the Platinum Group made sixty (60) separate trades, including numerous small trades of 20 shares or less. Perhaps not surprisingly, Echo's stock, which opened that day at $5.39 per share, closed at $3.97 per share. Consequently, stockholders experienced a single day drop in the value of their shares of approximately 26%. Only a few days later, when Echo's stock price closed between $2.46 and $2.78 per share, members of the Platinum Group purchased 1,016,388 shares of Echo's stock over a five-day trading period.
    Can that really be the case when Platinum's Chief Investment Officer, Mark Nordlicht, texted Echo's former CEO on the evening of January 31, 2013 and made the following threat? "U shd let mkt know we plan on selling every share down to a penny if u do new deal under 1.00 with new investors. Announce that @******."

  • Reply to

    The facts

    by soxfan10131013 May 12, 2014 11:31 AM
    disconnected6060842 disconnected6060842 May 12, 2014 1:15 PM Flag

    I did a nice trade on this on Friday but didn't dare hold on to it. That conference call was a little scary.

  • disconnected6060842 disconnected6060842 May 8, 2014 3:04 PM Flag

    From the Sidoti site: "For our upcoming event, we again wish to introduce companies that have sound fundamentals and intriguing stories, show fast growth and profitability, or otherwise hold great promise, yet are largely unknown to investors." I guess you don't have to meet all the criteria. If you have the $7,000 presenter fee, you're in.

  • Reply to

    Americans only

    by entendanceinvestors May 7, 2014 10:30 AM
    disconnected6060842 disconnected6060842 May 7, 2014 1:17 PM Flag

    Amazing. The pumptards are really out in force today.

  • Reply to

    still s POS

    by tullzeppthewho May 7, 2014 9:35 AM
    disconnected6060842 disconnected6060842 May 7, 2014 10:14 AM Flag

    Correct, they provided guidance, which happened to be lower than estimates... Reports Q1 (Mar) loss of $0.08 per share, $0.03 better than the Consensus Estimate of ($0.11); revenue rose to $0.75 mln (Up from $0) vs $0.92 m ln consensus.Co issues downside guidance for FY14, sees FY14 revs of $5-6 mln vs. $6.60 mln Consensus Estimate.

  • Reply to

    mother of all short squeezes on the horizon

    by trendtraveler Apr 24, 2014 9:37 AM
    disconnected6060842 disconnected6060842 Apr 24, 2014 11:01 AM Flag

    Not a lot of short interest.

    Date Short Interest % Change Avg. Daily Share Volume Days to Cover Split New Issue
    Mar 31, 2014 344,407 0.02 58,865 5.85 No No
    Mar 14, 2014 344,344 -0.73 121,124 2.84 No No
    Feb 28, 2014 346,887 -2.92 101,975 3.40 No No
    Feb 14, 2014 357,336 1.03 67,982 5.26 No No
    Jan 31, 2014 353,686 -0.23 84,255 4.20 No No
    Jan 15, 2014 354,484 0.01 181,914 1.95 No No

  • disconnected6060842 by disconnected6060842 Apr 24, 2014 9:58 AM Flag

    When googling them it's a little disturbing to find this page as the #2 search result - "Clients of Magna Group and Hanover Holdings - InvestorsHub."

    From the forum: This forum is about due diligence information regarding OTC stocks that have issued financings through toxic financiers Magna Group, LLC, Hanover Holdings and/or related entities.

  • disconnected6060842 disconnected6060842 Apr 23, 2014 4:00 PM Flag

    Lol. He lists "PDUFA Date on 6/16/14" on his board. Like he'll still own this in June.

  • disconnected6060842 disconnected6060842 Apr 16, 2014 2:16 PM Flag

    Fidgety Ed: Wow, you're hanging food inflation on Obama. That's a new one. I think it's time to check out of here, I'm losing brain cells reading this board lately. I'll check back in when we have notes from the FDA meeting or financing news. Adios.

0.200.00(0.00%)Jul 11 1:18 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.